Aberrant microRNA expression in multiple myeloma (Q38099048)

28 August 2017

title

Aberrant microRNA expression in multiple myeloma (English)

1 reference

28 August 2017

0 references

3

Kirsten Grønbæk

0 references

author name string

Konstantinos Dimopoulos

series ordinal

1

1 reference

28 August 2017

Peter Gimsing

series ordinal

2

1 reference

28 August 2017

Kirsten Grønbæk

series ordinal

3

1 reference

28 August 2017

publication date

5 June 2013

1 reference

European Journal of Haematology

28 August 2017

published in

1 reference

28 August 2017

volume

91

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

95-105

1 reference

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

28 August 2017

cites work

1 reference

21 January 2018

Pathogenesis of myeloma

1 reference

Latest advances and current challenges in the treatment of multiple myeloma

21 January 2018

1 reference

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

21 January 2018

1 reference

Role of genetics in prognostication in myeloma

21 January 2018

1 reference

The molecular classification of multiple myeloma

21 January 2018

1 reference

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.

21 January 2018

1 reference

The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma

21 January 2018

1 reference

DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer

21 January 2018

1 reference

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

21 January 2018

1 reference

MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival

21 January 2018

1 reference

Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence.

21 January 2018

1 reference

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

21 January 2018

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

Biogenesis of small RNAs in animals

21 January 2018

1 reference

MicroRNA mir-346 targets the 5'-untranslated region of receptor-interacting protein 140 (RIP140) mRNA and up-regulates its protein expression

21 January 2018

1 reference

MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation

21 January 2018

1 reference

microRNAs as oncogenes and tumor suppressors

21 January 2018

1 reference

Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy

21 January 2018

1 reference

Differential expression of microRNAs in hematopoietic cell lineages

21 January 2018

1 reference

MicroRNAs in erythroid and megakaryocytic differentiation and megakaryocyte-erythroid progenitor lineage commitment

21 January 2018

1 reference

A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis

21 January 2018

1 reference

Roles of BCL6 in normal and transformed germinal center B cells

21 January 2018

1 reference

Regulation of plasma-cell development

21 January 2018

1 reference

STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation.

21 January 2018

1 reference

The RNase III enzyme Dicer is essential for germinal center B-cell formation.

21 January 2018

1 reference

Patterns of microRNA expression characterize stages of human B-cell differentiation.

21 January 2018

1 reference

Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas

21 January 2018

1 reference

MicroRNA 125b inhibition of B cell differentiation in germinal centers

21 January 2018

1 reference

Regulation of the germinal center response by microRNA-155

21 January 2018

1 reference

microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells

21 January 2018

1 reference

miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model

21 January 2018

1 reference

BCL6 positively regulates AID and germinal center gene expression via repression of miR-155.

21 January 2018

1 reference

Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma

21 January 2018

1 reference

Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas

21 January 2018

1 reference

Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes

21 January 2018

1 reference

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma.

21 January 2018

1 reference

Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer

21 January 2018

1 reference

Identification of a novel microRNA cluster miR-193b-365 in multiple myeloma

21 January 2018

1 reference

High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2.

21 January 2018

1 reference

MicroRNA profiles of drug-resistant myeloma cell lines.

21 January 2018

1 reference

Identification of novel miR-21 target proteins in multiple myeloma cells by quantitative proteomics

21 January 2018

1 reference

Set9, NF-κB, and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells

21 January 2018

1 reference

Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth

21 January 2018

1 reference

miRiad roles for the miR-17-92 cluster in development and disease

21 January 2018

1 reference

Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma.

21 January 2018

1 reference

miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma

21 January 2018

1 reference

Pleiotropic anti-myeloma activity of ITF2357: inhibition of interleukin-6 receptor signaling and repression of miR-19a and miR-19b

21 January 2018

1 reference

Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)?

21 January 2018

1 reference

Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling.

21 January 2018

1 reference

miR-15a and miR-16-1 in cancer: discovery, function and future perspectives

21 January 2018

1 reference

MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma

21 January 2018

1 reference

Suppressing miRNA-15a/-16 expression by interleukin-6 enhances drug-resistance in myeloma cells

21 January 2018

1 reference

Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development

21 January 2018

1 reference

Micro-RNA-15a and micro-RNA-16 expression and chromosome 13 deletions in multiple myeloma.

21 January 2018

1 reference

The role of miRNA-29 family in cancer

21 January 2018

1 reference

Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1.

21 January 2018

1 reference

miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1

21 January 2018

1 reference

DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma.

21 January 2018

1 reference

Epigenetic inactivation of the MIR34B/C in multiple myeloma.

21 January 2018

1 reference

Epigenetic silencing of MIR203 in multiple myeloma.

21 January 2018

1 reference

MicroRNA biogenesis and regulation of bone remodeling

21 January 2018

1 reference

miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease

21 January 2018

1 reference

The miR-34 family in cancer and apoptosis

21 January 2018

1 reference

p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC.

21 January 2018

1 reference

miRandola: extracellular circulating microRNAs database

21 January 2018

1 reference

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

Plasma components affect accuracy of circulating cancer-related microRNA quantitation

21 January 2018

1 reference

Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders

21 January 2018

1 reference

Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma

21 January 2018

1 reference

Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma.

21 January 2018

1 reference

Role for microRNAs in regulating glucocorticoid response and resistance in multiple myeloma

21 January 2018

1 reference

Triptolide enhances the sensitivity of multiple myeloma cells to dexamethasone via microRNAs

21 January 2018

1 reference

Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cells

21 January 2018

1 reference

RNA-based therapeutics: current progress and future prospects.

21 January 2018

1 reference

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

21 January 2018

1 reference

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

21 January 2018

1 reference

21 January 2018

1 reference

Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du M

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/EJH.12124

1 reference

28 August 2017

1 reference